Audience:

Drugs

Level:

Intermediate/Advanced


Who Attended

  • Attorneys, regulatory staff and compliance personnel who work with manufacturers of controlled substances 
  • Regulatory affairs professionals and scientists who work in the area of controlled substances  
  • Pharmacists, medical professionals, public health and consumer advocates, and other individuals working with controlled substances 
  • Academics and other research organizations and members of the press who study and/or report on issues related to controlled substances 

This one-day conference focused on significant developments in FDA and DEA’s regulation of controlled substances. The program brought together government, industry and public interest experts to provide updates on the latest regulations and legislation affecting controlled substances’ stakeholders. Participants discussed key developments after passage of the Food and Drug Administration Safety and Innovation Act (FDASIA); opioid REMS requirements; and important scheduling and re-scheduling cases from the past year.  Panelists engaged attendees in interactive dialogue on current hot topics and ongoing legal and policy decisions.


Attendees at our 2012 Controlled Substances Conference included representatives from the following companies:

Arnold & Porter LLP
Cadwalader, Wickersham & Taft LLP
Cardinal Health, Inc.
Covidien
Covington & Burling LLP
Department of Justice
Drug Enforcement Administration
Eisai Inc.
Eli Lilly and Company
Endo Pharmaceuticals Inc.
FDA - CDER
FDA - CVM
FDA - OC
FDAImports.com, LLC
Federal Trade Commission
Healthcare Distribution Management Association
Henry Schein, Inc.
Hogan Lovells LLP
Hyman, Phelps & McNamara, P.C.
Jazz Pharmaceuticals, Inc.
Johnson & Johnson 
K&L Gates LLP

Kleinfeld, Kaplan & Becker, LLP
Krieg DeVault LLP
Leavitt Partners, LLC
National Association of Chain Drug Stores
Noramco, Inc.
North Carolina Board of Pharmacy
Otsuka America Pharmaceutical, Inc.
Parsons Behle & Latimer
Pfizer, Inc.
Pharma Compliance Group, Inc.
Pharmaceutical Education & Research Institute, Inc. (PERI)
PhRMA
Pinney Associates, Inc.
Prescription Drug Research Center LLC
Purdue Pharma L.P.
PWR
Shire Specialty Pharmaceuticals
State University of NY at Buffalo
The Drug & Chemical Advisory Group, LLC
Trends-in-Medicine
U.S. Pharmacopeia
United BioSource Corporation
University of Maryland School of Pharmacy